The FDA appointed Rick Abramson, formerly a chief medical officer at an AI health company, as the new director of its Digital Health Center of Excellence, signaling a push towards less stringent regulation of AI products in healthcare. This move is significant for content creators in digital health and AI, indicating a potential shift towards more flexible regulatory oversight that could facilitate innovation and market entry.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



